Product-type market taxonomy partitions the arthroscopy sector into disposables, implants, and integrated capital systems. Disposable instrumentationโshavers, burrs, sutures, and suture-passersโyields 38 % of category revenue, benefiting from single-use conversion that lowers sterilisation costs but demands high SKU breadth. Implantable fixation devices (anchors, interference screws, and suture buttons) claim 34 %, with knotless and biocomposite variants commanding >20 % price premiums over conventional PEEK equivalents yet facing tender-driven ASP erosion in Europe. Capital equipmentโ4K cameras, radio-frequency wands, and fluid-management consolesโrepresents 20 %; replacement cycles lengthen as hospitals defer capital outlays, while ambulatory centres favour bundled rental models. Accessory and service revenue (9 %) encompasses seals, tubing, and annual maintenance contracts, offering vendors stable annuities that smooth capital-sales volatility.